231 results on '"Dan, Yock Young"'
Search Results
2. Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH
3. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver
4. A multimodal atlas of hepatocellular carcinoma reveals convergent evolutionary paths and ‘bad apple’ effect on clinical trajectory
5. Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
6. Platform for the interdisciplinary study of cardiovascular, metabolic and neurovascular diseases (PICMAN) protocol
7. Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment
8. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis
9. Rising global burden of cancer attributable to high BMI from 2010 to 2019
10. Global Prevalence, Clinical Characteristics, Surveillance, Treatment Allocation, and Outcomes of Alcohol-Associated Hepatocellular Carcinoma
11. Sequential SAFE Score and Transient Elastography for Detecting Significant Fibrosis in Asian Patients with MASLD
12. NASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
13. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals
14. UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies
15. Systemic Non-infectious Hepatitis
16. Contributors
17. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis
18. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
19. Outcomes of Nonalcoholic Steatohepatitis After Liver Transplantation: An Updated Meta-Analysis and Systematic Review
20. THU-200-YI Clearance of senescent cells alleviates metabolic dysfunction-associated steatohepatitis
21. SAT-281 Clinical characteristics, surveillance, treatment allocation and outcomes of alcohol-related hepatocellular carcinoma: meta-analysis of 37 studies and 66, 559 patients
22. WED-238 High pancreatic fat and reduced volume stratify patients with F4 liver fibrosis
23. Single-cell and spatial atlas of steatotic liver-related hepatocellular carcinoma
24. Pan-cancer pervasive upregulation of 3′ UTR splicing drives tumourigenesis
25. A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease
26. Hepatocellular carcinoma organoid co-cultures mimic angiocrine crosstalk to generate inflammatory tumor microenvironment
27. A systematic review and meta-analysis on the impact of pre-existing and new-onset atrial fibrillation on outcomes before and after liver transplantation
28. Rational drug combination design in patient-derived avatars reveals effective inhibition of hepatocellular carcinoma with proteasome and CDK inhibitors
29. Trajectory of immune evasion and cancer progression in hepatocellular carcinoma
30. Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT
31. Global Prevalence, Risk Factors, and Outcomes of Depression After Liver Transplant: A Systematic Review and Meta-analysis
32. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
33. The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
34. Clinical Service Incorporating Mobile Technology on Weight Loss in Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease: A Translation From Research Trial
35. Targeting RNA editing of antizyme inhibitor 1: A potential oligonucleotide-based antisense therapy for cancer
36. A network meta-analysis of direct oral anticoagulants for portal vein thrombosis in cirrhosis
37. Outcomes of a multi-ethnic Asian population on combined treatment with clopidogrel and omeprazole in 12,440 patients
38. Depression in non-alcoholic fatty liver disease is associated with an increased risk of complications and mortality
39. GI-COVID: Are There COVID-19 Patients with Primary Gastrointestinal SARS-CoV-2 Infection and Symptoms?
40. Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
41. Rising global burden of cancer attributable to high BMI from 2010 to 2019
42. Emerging liver organoid platforms and technologies
43. Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
44. Singapore’s Experience in Managing the COVID-19 Pandemic: Key Lessons from the Ground
45. Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females
46. Performance of non-invasive markers in evaluating presence and severity of liver fibrosis in non-alcoholic fatty liver disease: results from a multi-ethnic Asian cohort of biopsy-proven non-alcoholic fatty liver disease patients
47. Evaluating the role of novel magnetic resonance imaging-based biomarkers in non-invasive assessment of hepatic fibrosis and activity in non-alcoholic fatty liver disease
48. SAFE score yielded a better performance than FIB-4 and NFS in predicting significant fibrosis among Asian NAFLD patients
49. Comparison of performance of non-invasive indices in assessing degree of steatosis in non-alcoholic fatty liver disease
50. Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.